Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study

OBJECTIVE: To evaluate the durability of response 3 months after the third BNT162b2 vaccine in adults aged 60 years and older. DESIGN: Prospective cohort study. SETTING: Single tertiary centre. PARTICIPANTS: Healthcare workers/family members aged ≥60 years old who received the third BNT162b2 dose. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Eliakim-Raz, Noa, Stemmer, Amos, Leibovici-Weisman, Yaara, Ness, Asaf, Awwad, Muhammad, Ghantous, Nassem, Erez, Noam, Bareket-Samish, Avital, Levy-Barda, Adva, Ben-Zvi, Haim, Moskovits, Neta, Bar-Haim, Erez, Stemmer, Salomon M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350740/
https://www.ncbi.nlm.nih.gov/pubmed/35918111
http://dx.doi.org/10.1136/bmjopen-2022-061584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350740/
https://www.ncbi.nlm.nih.gov/pubmed/35918111
http://dx.doi.org/10.1136/bmjopen-2022-061584

Ejemplares similares